United States Federal Circuit

Reset A A Font size: Print

Orexo AB v. Actavis Elizabeth LLC, 17-1333

Reversed a judgment that a patent for a pharmaceutical product was invalid on the ground of obviousness. The Federal Circuit concluded that obviousness was not proved by clear and convincing evidence.

Appellate Information

  • Decided
  • Published 2018/09/10


  • Newman


  • United States Federal Circuit


Copied to clipboard